Advertisement

Topics

Latest "Arquer Diagnostics Ltd" News Stories

20:21 EDT 25th April 2017 | BioPortfolio

Here are the most relevant search results for "Arquer Diagnostics Ltd" found in our extensive news archives from over 250 global news sources.

More Information about Arquer Diagnostics Ltd on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Arquer Diagnostics Ltd for you to read. Along with our medical data and news we also list Arquer Diagnostics Ltd Clinical Trials, which are updated daily. BioPortfolio also has a large database of Arquer Diagnostics Ltd Companies for you to search.

Showing "Arquer Diagnostics" News Articles 1–25 of 5,200+

Tuesday 25th April 2017

Instrumentation Laboratory Company Medical Equipment Deals and Alliances Profile [Updated: 24012017] Prices from USD $250

SummaryInstrumentation Laboratory Company IL, a subsidiary of Werfen Life Group, is a medical device company with focus on in vitro diagnostics IVD devices. The company develops, manufactures, and distributes IVD instruments, related reagents and controls for hospitals and clinical laboratories. Its major products include critical care systems including whole blood analyzers, COOximeter and wholeb...


i2 Pharmaceuticals Appoints Chief Business Officer

BOULDER, Colo., April 25, 2017 /PRNewswire/ -- i2 Pharmaceuticals, Inc., a biopharmaceutical company focused on next generation discovery and development of therapeutics with a focus on personalized cancer treatment, announced that Mark F. Kubik has joined the company in the role of Chief Business Officer effective February 1, 2017. Mr. Kubik will report to Dr. Bruce Eaton, i2's Founder, Chai...

SAB Biotherapeutics Names Christoph Bausch as Chief Science Officer

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company, today officially announced the hire of Christoph L. Bausch, Ph.D. as its Chief Science Officer (CSO). Dr. Bausch joins SAB’s executive team as an experienced research scientist and business development executive who has led the successful discovery, develop...


Biocom Calls for Life Science Catalyst Award Nominations

SAN DIEGO, April 25, 2017 /PRNewswire/ -- Biocom, the association representing the California life science industry, today announced a call for entries for the second annual Life Science Catalyst Awards. In addition, Biocom announced that it is adding a second region from which it is seeking nominees to include Los Angeles County.  L.A. will have its own nominees, judges and Catalyst Awa...

DermTech Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Updated: 20032017] Prices from USD $250

SummaryDermTech Inc DermTech is a biotechnology company that develops and validates molecular tests using specimens derived from the skin. The company's products include adhesive skin sample collection kit and pigmented lesion assay. Its EGIR platform technology is applicable in noninvasive, genomicbased disease detection, theranostics, pharmaceutical research and development, and cosmeceutical de...

Former Pathology, Inc. CEO Vicki DiFrancesco Joins XIFIN as Chief Strategy Officer

XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has appointed Vicki DiFrancesco as its Chief Strategy Officer. DiFrancesco, one of the most influential leaders in the la

New Stago Webinar Offers Insight on Coagulation Testing for Disseminated Intravascular Coagulation

LabRoots will host the webinar April 28, discussing the basic pathophysiology of Disseminated Intravascular Coagulation (DIC), along with diagnostic and management approaches. Yorba Linda, Ca (PRWEB) April 25, 2017 As part of the Stago EdVantage Virtual University Virtual Event, the latest webinar in the series will explore the laboratory testing for DIC in order to illuminate this clinical probl...

Hill-Rom Introduces Monarch™ Airway Clearance System

CHICAGO, April 25, 2017 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC), a leading global medical technology company, today announced the introduction of the Monarch™ Airway Clearance System. Building on decades of leadership with The Vest® Airway Clearance System, the Monarch system represents Hill-Rom's debut in mobile therapy and the next chapter in the company's patient-centered re...

MPEG LA Invites CRISPR-Cas9 Patents to be Pooled in a One-Stop License

Accessibility to a multi-user market will maximize CRISPR’s life-enhancing potential World licensing leader MPEG LA, LLC today invited holders of CRISPR-Cas9 patents to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform that will make their groundbreaking technologies widely accessible. “Pooling the foundat...

Predictive Machine Learning in Somnoware Enables Proactive Therapy Compliance Management

The new predictive analytics feature in Somnoware’s care management module enables sleep physicians to estimate a patient’s likelihood of therapy compliance and intervene accordingly. Santa Clara, CA (PRWEB) April 25, 2017 Somnoware, a leading provider of digital health technology, announces the addition of predictive analytics to its patient care management module. Using this new feature, sl...

Asuragen Strengthens Repetitive Sequence and Short Structural Variant Intellectual Property Portfolio

Asuragen, Inc., a global molecular diagnostics company, announced today the award of a patent (EP 2,411,532 B1) from the European Patent Office for PCR methods that analyze the presence of an interrupter sequence in CGG-rich regions of the fragile X mental retardation (FMR1) gene. This latest patent further strengt

Two Pore Guys Raises $24.5 Million in Series A Financing

Investment Led by Khosla Ventures with Eye on Developing an Industry for Diagnostics Based on the 2PG Platform Two Pore Guys, Inc. (2PG), today announced the close of a Series A venture financing round in the amount of $24.5 million, led by Khosla Ventures. The new funding will be used to scale up manufacturing of 2PG’s hand-held, point-of-use testin...

FDA takes action against 14 companies for selling illegal cancer treatments

SILVER SPRING, Md., April 25, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer. The products are marketed and sold without FDA approval, most commonly on websites and social media platforms. "Consumer...

Laboratory Corporation of America® Holdings Announces 2017 First Quarter Results and Updates 2017 Guidance

Q1 Net revenue of $2.4 billion, up 5% over last year Q1 Diluted EPS of $1.84, up 16% over last year; Q1 Adjusted EPS of $2.22, up 8% over last year Q1 Free Cash Flow of $162 million, up 188% over last year 2017 Adjusted EPS guidance updated to $9.20 to $9.60, up 4% to 9% over 2016 ...

Automation-Friendly Kit for Capture of Circulating Free DNA and Liquid Biospy

AMSBIO has announced the launch of its new cfPure™ Cell Free DNA Purification Kit for scalable and automation-friendly isolation of circulating cell-free DNA (cfDNA) from patient serum or plasma samples. Circulating cfDNA is normally comprised of DNA fragments from healthy cells.  However, apoptotic cells, necrotic cells, cancer cells, and intact cells all release cfDNA into the bloodst...

AltheaDx Closes $27 Million Series D Financing

SAN DIEGO, April 25, 2017 /PRNewswire/ -- AltheaDx, Inc. ("AltheaDx" or the "Company"), a commercial stage molecular diagnostics company specializing in the field of personalized medicine, today announced that it has raised $27 million in its Series D funding. The Series D funding will provide operating capital as AltheaDx expands its sales force and scales up marketing efforts following...

Strathspey Crown Aligns Asset Portfolio

NEWPORT BEACH, Calif., April 25, 2017 /PRNewswire/ -- Strathspey Crown LLC announced today a new alignment of its asset portfolio held in affiliate Strathspey Crown Holdings LLC.  As part of this alignment effort, Strathspey Crown Holdings was renamed SCH-AEON LLC to signify its core focus upon its majority-ownership (76% equity ownership) in subsidiary, ALPHAEON Corporation, with second...

Doc Halo Raises $11 Million to Transform Real-Time Clinical Communication

CINCINNATI, April 25, 2017 /PRNewswire/ -- Doc Halo, a pioneer in real-time clinical communication, today announced that it has raised $11 million in Series A funding, led by Bain Capital Ventures with additional investment from Refinery Ventures. This marks the first time Doc Halo has partnered with outside investors in its seven-year history. The funds will allow the company to accelerate growth...

Alere Launches the Alere™ Malaria Ag P.f, the First-Ever Rapid Test to Screen Malaria Infection in Asymptomatic Individuals

WALTHAM, Mass., April 25, 2017 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced the launch of its Alere™ Malaria Ag P.f, a major technological breakthrough in high-sensitivity rapid testing versus currently available malaria RDTs (rapid diagnostic tests). The Alere Malaria Ag P.f offers a greater than tenfold improvement in the detection of h...

Wide Application of Big Data Analytics Transform entire Healthcare Value Chain

LONDON, April 25, 2017 /PRNewswire/ -- The transformative potential of Big Data analytics (BDA) will be the key to unlocking opportunities in a variety of applications, including precision medicine, remote patient monitoring, drug development, and advanced cancer therapy. The technology has already set in motion changes across the value chain by enhancing health monitoring, personalised healthcare...

Monday 24th April 2017

Lateral Flow Assay Market by Product Reader, Kits Application Clinical Testing Pregnancy, Infectious Disease, Cholestrol, Cardiac Marker, Veterinary, Drug Development Technique Sandwich, Competitive, Multiplex End User Global Forecast to 2020 [Updated: 1

The global lateral flow assay market is expected to grow at a strong CAGR of 8.3% during the forecast period of 2015 to 2020 and is estimated to reach USD 6.78 billion by 2020. The growth in this market is majorly driven by the rising geriatric population, high prevalence of infectious diseases, rising usage of homebased lateral flow assay tests, improved focus on decentralized or pointofcare diag...

1Drop Diagnostics and Massachusetts General Hospital Clinicians Collaborate on Next Generation Portable Medical Diagnostics

NEUCHATEL, Switzerland AND BOSTON, April 25, 2017 /PRNewswire/ -- 1Drop Diagnostics, a Switzerland- and Boston-based medical diagnostics and life sciences company, has announced that the funding of their collaboration with clinicians at the Massachusetts General Hospital (MGH) on portable medical diagnostics of heart disease in primary care settings has been continued by the Consortia for Improvin...

Aurora Diagnostics Commences Private Exchange Offer and Consent Solicitation for All of Its Outstanding 10.750% Senior Notes Due 2018

Aurora Diagnostics Holdings, LLC (the “Company”) today announced that it, together with its wholly-owned subsidiary, Aurora Diagnostics Financing, Inc. (“Aurora Financing” and together with the Company, the “Issuers”), have commenced a private exchange offer (the “Exchange Offer”) for all of their outstanding 10.750% Senior Notes due 2018 (the ...

Treos Bio Names Group of Leading Clinical and Regulatory Experts to Clinical Advisory Board

SAN FRANCISCO, CA and LONDON, UNITED KINGDOM -- (Marketwired) -- 04/25/17 -- Treos Bio, which is developing precision therapeutic cancer vaccines as well as companion diagnostics, today announced the appointment of a group of leading experts to its newly established Clinical Advisory Board. "We are fortunate to have attracted such an accomplished group of experts to serve on the advisory board, ...

Aurora Diagnostics Inc. Commences Private Exchange Offer And Consent Solicitation For All Of Its Outstanding 10.750% Senior Notes Due 2018

  Life Sciences Jobs   ...


Quick Search
Advertisement
 

News Quicklinks